Logo image
Dr. Lugui Qiu working place, Beijing GoBroad Boren Hospital
Dr. Lugui Qiu
Excellent
AiroScore
9.70

Dr. Lugui Qiu

oncology, hematology, myeloma treatment
oncology, hematology, myeloma treatment
User ScoreRatingPrice RangePublicationsMedia FilesOnline Consultations
98%9.7/10$$256No

Overview

Country, City
China, Beijing
Health facility
Beijing GoBroad Boren Hospital
Medical unit
Department of adult myeloma and lymphoma

About the doctor

Dr. Lugui Qiu is a renowned oncologist and hematologist with a wealth of experience in adult myeloma treatment. Holding roles such as Chief Scientist at GoBroad Healthcare Group Myeloma Research Institute and Director of the Lymphoma Diagnosis and Treatment Center at the Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Dr. Qiu is widely recognized for his expertise in the field. He is a member of prestigious organizations like the International Myeloma Society (IMS) and the Expert Committee of the International Myeloma Working Group (IMWG), showcasing his dedication to advancing research and treatment in oncology. With impressive roles, including Editor, Board Member of Blood Advances, and Executive Director of the 9th Council of the Chinese Anti-Cancer Association (CACA), Dr. Qiu's impact and contributions to the field of hematology and oncology are evident. His upcoming role as Chairman of the Myeloma Expert Committee highlights his leadership and commitment to improving patient care. Dr. Lugui Qiu continues to make significant strides in the fight against cancer through his involvement in various committees, societies, and research initiatives.

Skills & Expertise

myeloma
multiple myeloma
lymphoma
proteasome
autophagy
oncology
bone marrow
myeloma targeting
proteasome autophagy
myeloma treatment
adult myeloma
myeloma research
lymphoma diagnosis
adult myeloma treatment
lymphoma diagnosis treatment
multiple myeloma targeting
hematology
marrow
targeting proteasome
myeloma progression
hematology adult
myeloma dualregulation
dualregulation proteasome
myeloma cell
myeloid cells
myeloma cells
oncologist
hematologist
prognosis multiple myeloma
mantle cell lymphoma
large bcell lymphomas
diagnosed multiple myeloma
hematology adult myeloma
cells multiple myeloma
myeloma slow remission
immune responses myeloma
reprogramming multiple myeloma
multiple myeloma dualregulation
immunosuppressive myeloid cells
tumor cells
heparanase multiple myeloma
blood multiple myeloma
normal plasma cells
monocytes bone marrow
dualregulation proteasome autophagy
dyscrasias
plasma cell dyscrasias
cells bone marrow
multiple myeloma analysis
cell dyscrasias

Gallery

Resume

CV (Curriculum Vitae)

Education
  • Chief scientist at GoBroad Healthcare Group Myeloma Research Institute
  • Director of the Lymphoma Diagnosis and Treatment Center at the Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
Experience
  • State council special allowance expert of the State Council of the Republic of China
  • Outstanding contribution mid-aged expert from the National Health Commission
  • Member of the International Myeloma Society (IMS)
  • Member of the Expert Committee of the International Myeloma Working Group (IMWG)
  • Editorial Board Member of Blood Advances and six other core journals including the Chinese Journal of Hematology
  • Executive Director of the 9th Council of the Chinese Anti-Cancer Association (CACA)
  • Chairman of the Myeloma Expert Committee (in preparation)
  • Vice chairman of the Lymphoma Expert Committee of the Chinese Society of Clinical Oncology (CSCO)

Languages

English flag
English
Chinese flag
Chinese

Publications

Lymphoma cell-driven IL-16 is expressed in activated B-cell-like diffuse large Bcell lymphomas and regulates the pro-tumor microenvironment.

26 September, 2024

DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways

24 September, 2024

OA-31 TRIM28 Functions as a Key Protein Homeostasis Regulator and Mediates Proteasome Inhibitor Resistance in MM

1 September, 2024

FAQ

Where does the doctor practice?

What is the specialization of Dr. Lugui Qiu?

The primary specialization of the doctor is oncology, hematology, myeloma treatment.

What is the rating of the doctor?

Dr. Lugui Qiu is rated as 9.70 by AiroMedical.

What topics does Dr. Lugui Qiu expert at?

The doctor has excellent knowledge in myeloma, multiple myeloma, lymphoma, proteasome, autophagy.

Is the specialist involved in the research?

Where can I see the work of the doctor?

AiroMedical gallery has 6 images related to Dr. Lugui Qiu.

Does the specialist offer online consultations?

No, Dr. Lugui Qiu doesn’t perform virtual appointments.

Dr. Lugui Qiu
Dr. Lugui Qiu

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Dr. Lugui Qiu

Similar Doctors

Excellent
AiroScore
9.90
Beijing GoBroad Boren Hospital
hematology, hematooncology, malignant tumors
Excellent
AiroScore
9.90
Beijing GoBroad Boren Hospital
hematology, oncology, stem cell transplantation
Excellent
AiroScore
9.90
Beijing GoBroad Boren Hospital
oncology, hematology, pediatric immunotherapy, pediatric hematology
Excellent
AiroScore
9.90
Beijing GoBroad Boren Hospital
oncology, hematology, oncological lab diagnostics
Excellent
AiroScore
9.90
Beijing GoBroad Boren Hospital
oncology, hematology, lymphoma, myeloma
Excellent
AiroScore
9.90
Beijing GoBroad Boren Hospital
oncology, hematology, lymphoma and myeloma
Excellent
AiroScore
9.80
Beijing GoBroad Boren Hospital
oncology, hematology, oncohematology, immunotargeting therapy
Excellent
AiroScore
9.80
Beijing GoBroad Boren Hospital
hematology, oncology, hematopoietic system diseases
Excellent
AiroScore
9.80
Beijing GoBroad Boren Hospital
oncology, hematology, integrated diagnostics